Detalhe da pesquisa
1.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642837
2.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988749
3.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183733
4.
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).
Angiogenesis
; 23(2): 193-202, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773439
5.
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Br J Cancer
; 122(6): 759-765, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001832
6.
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies.
Breast Cancer Res Treat
; 179(2): 387-401, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620934
7.
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications.
Breast Cancer Res
; 21(1): 65, 2019 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101122
8.
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.
PLoS Med
; 16(12): e1002989, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31869400
9.
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial).
BMC Cancer
; 18(1): 526, 2018 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29728098
10.
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 17(5): 600-11, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032301
11.
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609).
Cancer
; 122(19): 3032-40, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27315583
12.
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
Future Oncol
; 11(16): 2283-97, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260807
13.
Bias reduction using combined stain normalization and augmentation for AI-based classification of histological images.
Comput Biol Med
; 171: 108130, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387381
14.
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.
EBioMedicine
; 104: 105141, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718683
15.
Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.
Breast Cancer Res Treat
; 139(3): 789-800, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23780683
16.
SHARE: a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence.
Clin Adv Hematol Oncol
; 11(2): 76-83, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598908
17.
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial.
Radiother Oncol
; 187: 109818, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480995
18.
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 9(10): 1381-1389, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561451
19.
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
BMJ Open
; 12(3): e055821, 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241469
20.
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer.
NPJ Breast Cancer
; 8(1): 3, 2022 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017545